(Q30318384)

English

Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

7

0 references

Sebastian Nuding

1

0 references

5

0 references

Ursula Müller-Werdan

6

object named as

Ursula Müller-Werdan

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

author name string

Henning Ebelt

2

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Robert S Hoke

3

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Annette Krummenerl

4

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

publication date

3 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Clinical Research in Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

915-923

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Ivabradine for the treatment of stable angina pectoris in octogenarians

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Early goal-directed therapy in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Metabolism modulators in sepsis: propranolol

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Reversal of catabolism by beta-blockade after severe burns

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Beta-blockade during sepsis: inspired or insane?

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Vascular pathophysiology in response to increased heart rate

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Heart rate reduction--a mechanism of benefit?

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Drug insight: If inhibitors as specific heart-rate-reducing agents

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Autonomic dysfunction in the ICU patient

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Impaired regulation of cardiac function in sepsis, SIRS, and MODS.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shock.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Association of tachycardia with morbidity and mortality: pathophysiological considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Septic cardiomyopathy - A not yet discovered cardiomyopathy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endotoxin impairs the human pacemaker current If.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Autonomic dysfunction and beta-adrenergic blockers in multiple organ dysfunction syndrome]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The multifactor primary prevention trial in Göteborg, Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00392-011-0323-2

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30318384&oldid=2194741163"